共 101 条
[1]
Neri RO(1972)A biological profile of a nonsteroidal antiandrogen, SCH13521(4′-nitro-3′trifluoromethyliso-butyranilide). Endocrinology 91 427-37
[2]
Florance K(1972)Effects of novel nonsteroidal antiandrogen on canine prostatic hyperplasia. Invest Urol 10 123-30
[3]
Koziol P(1989)Combination therapy with castration and flutamide: today's treatment of choice for prostate cancer. J Steroid Biochem 33 817-21
[4]
Neri RO(2004)Microarray analysis of changes in renal phenotype in the ethylene glycol rat model of urolithiasis: potential and pitfalls. BJU Int 93 637-50
[5]
Monahan M(2004)The use of flutamide as a single antiandrogen treatment for hormone-refractory prostate cancer. BJU Int 93 1119-20
[6]
Labrie F(1999)Fulminant liver failure associated with flutamide therapy for hirsutism. Lancet 353 983-6
[7]
Dupont A(1975)The treatment of benign prostatic hypertrophy with flutamide: a placebo controlled study. J Urol 114 564-6
[8]
Cusan L(1975)Placebo-controlled double-blind study in human benign obstructive prostatic hypertrophy with flutamide. Eur Urol 2 24-8
[9]
Manhes G(2004)Toxic hepatitis and liver failure under therapy with flutamide. Internist (Berl) 45 333-40
[10]
Bergeron N(1992)Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. Am J Med 92 465-70